N-terminal degradation activates the NLRP1B inflammasome

Ashley J. Chui, Marian C. Okondo, Sahana D. Rao, Kuo Gai, Andrew R. Griswold, Darren C. Johnson, Daniel P. Ball, Cornelius Y. Taabazuing, Elizabeth L. Orth-He, Brooke A. Vittimberga,

Science · 2019 · 295 citations · 31 references

DOIFull text

Open access

Concepts

TL;DR

Intracellular pathogens and danger signals trigger inflammasomes that activate inflammatory caspases and induce pyroptosis. The study aims to elucidate the molecular mechanism by which anthrax lethal factor and DPP8/9 inhibitors activate the NLRP1B inflammasome. Genome‑wide CRISPR‑Cas9 knockout screens identified genes required for NLRP1B‑mediated pyroptosis, revealing that lethal factor cleaves NLRP1B and that its N‑terminus is degraded via the N‑end rule proteasomal pathway. Both lethal factor and DPP8/9 inhibitors induce N‑terminal degradation of NLRP1B, with lethal factor using the N‑end rule pathway, establishing N‑terminal degradation as the common activation mechanism of this innate immune sensor.

Abstract

Intracellular pathogens and danger signals trigger the formation of inflammasomes, which activate inflammatory caspases and induce pyroptosis. The anthrax lethal factor metalloprotease and small-molecule DPP8/9 inhibitors both activate the NLRP1B inflammasome, but the molecular mechanism of NLRP1B activation is unknown. In this study, we used genome-wide CRISPR-Cas9 knockout screens to identify genes required for NLRP1B-mediated pyroptosis. We discovered that lethal factor induces cell death via the N-end rule proteasomal degradation pathway. Lethal factor directly cleaves NLRP1B, inducing the N-end rule-mediated degradation of the NLRP1B N terminus and freeing the NLRP1B C terminus to activate caspase-1. DPP8/9 inhibitors also induce proteasomal degradation of the NLRP1B N terminus but not via the N-end rule pathway. Thus, N-terminal degradation is the common activation mechanism of this innate immune sensor.

References

31